Recombinant Shingles Vaccine Linked to Lower Dementia Risk
A U.S. study found that receiving the recombinant herpes zoster vaccine (RZV, shingles vaccine) was associated with a significantly lower risk of developing dementia among older adults admitted to skilled-nursing facilities. Researchers analyzed data from 509,926 Medicare beneficiaries aged 66 years or older who had no prior dementia diagnosis and […]